PCO371 is an orally active full agonist of parathyroid hormone receptor 1 (PTHR1) , with no effect on PTH type 2 receptor. In Vitro PCO371 is an orally active full agonist of parathyroid hormone receptor 1 (PTHR1), with no effect on PTH type 2 receptor. PCO371 induces cAMP production with an EC 50 of 2.4 μM in COS-7 cells expressing hPTHR1, and 2.5 μM in COS-7 cells transfected with hPTHR1-delNT, and also enhances the phospholipase C activity (EC 50 , 17 μM). MCE has not independently confirmed the accuracy of these methods. They are for reference only. Form:Solid IC50& Target:PTHR1
All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry
PCO371
CAS number:1613373-33-3 molecular formula:C29H32F3N5O6S
overview
compound introduction
Specs
| Chinese alias | - | ||
| English alias | EX-A2839 | DB14946 | HY-100856 | BCP31012 | SB19668 | MS-30887 | AKOS040742371 | UNII-TE53TU0WSQ | SCHEMBL17104864 | PCO371 | PCO-371 | GTPL12788 | LDZJFVOUPUFOHX-UHFFFAOYSA-N | PC-0371 | BDBM64562 | US9428505, Compound 7 | AC-31576 | 2,4-Imidazolidinedio | ||
| CAS number | 1613373-33-3 | molecular formula | C29H32F3N5O6S |
| molecular weight | 635.65 g/mol | Exact mass | ≥98% |
| PSA | 146.000 Ų | logp | 3.700 |
numbering system
No numbering system information yet
physicochemical properties
No physical and chemical property information yet
Safety information
No safety information yet
Production methods and uses
No production method and use information yet
Related
upstream information
No upstream information yet
downstream information
No downstream information yet
MSDS
Found 0 shareMSDS





